دورية أكاديمية
أعرض في EDS

Ocular Adverse Effects of Over-the-Counter Cosmetics and Personal Care Products Reported to the Food and Drug Administration.

التفاصيل البيبلوغرافية
العنوان: Ocular Adverse Effects of Over-the-Counter Cosmetics and Personal Care Products Reported to the Food and Drug Administration.
المؤلفون: Zhu A; Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A., Aftab OM; Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A., Mahajan J; Department of Ophthalmology, SUNY Downstate, Brooklyn, New York, U.S.A., Burkat CN; Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, U.S.A.
المصدر: Ophthalmic plastic and reconstructive surgery [Ophthalmic Plast Reconstr Surg] 2024 Aug 13. Date of Electronic Publication: 2024 Aug 13.
Publication Model: Ahead of Print
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins for the American Society of Ophthalmic Plastic and Reconstructive Surgery Country of Publication: United States NLM ID: 8508431 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-2677 (Electronic) Linking ISSN: 07409303 NLM ISO Abbreviation: Ophthalmic Plast Reconstr Surg Subsets: MEDLINE
أسماء مطبوعة: Publication: 199 - : Hagerstown, MD : Lippincott Williams & Wilkins for the American Society of Ophthalmic Plastic and Reconstructive Surgery
Original Publication: [New York, NY : Raven Press Publishers], c1985-
مستخلص: Purpose: Personal care and cosmetic products can cause periocular and ocular adverse effects (AEs), for example, ocular surface disease, trauma, and hypersensitivity. The publicly available Food and Drug Administration (FDA) Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS) database includes AE reports by consumers, healthcare practitioners, and manufacturers. The purpose of this study was to characterize ophthalmic AE associated with cosmetics and personal care products reported by the FDA CAERS database.
Methods: AE related to the eye or ocular adnexa from cosmetics submitted by consumers, healthcare practitioners, and manufacturers from January 2004 to June 2022 were identified after filtering using the Medical Dictionary for Regulatory Activities coding system. Demographic information, case outcome, and categories of product and AE were included. Chi-square analysis, with statistical significance at a = 0.05, was performed to ascertain variation in ocular, periocular, and general outcomes by product category.
Results: Reports of ophthalmic AEs related to cosmetics per year increased from 2006 to 2018, reaching a maximum of 161 reports in 2018, then decreased from 2018 to 2021. In total, 959 and 1382 unique periocular and ocular AEs were reported. There were 1711 total incidences of reported periocular AEs and 2485 ocular AEs. The most reported periocular AEs were inflammation (770/1711) and hypersensitivity (331/1711). The most reported ocular effects were discomfort (946/2485) and inflammation (709/2485). Ocular, periocular, and general outcomes significantly varied by product category.
Conclusions: Consumers, healthcare practitioners, and manufacturers should be made aware of potential ophthalmic AE and outcomes associated with cosmetics and personal care products.
Competing Interests: The authors have no financial or conflicts of interest to disclose.
(Copyright © 2024 The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc.)
References: Arai T, Nittono H. Cosmetic makeup enhances facial attractiveness and affective neural responses. PLoS One 2022;17:e0272923.
Matsushita S, Morikawa K, Yamanami H. Measurement of eye size illusion caused by eyeliner, mascara, and eye shadow. J Cosmet Sci 2015;66:161–174.
Yazdani M, Elgstøen KBP, Utheim TP. Eye make-up products and dry eye disease: a mini review. Curr Eye Res 2022;47:1–11.
Masud M, Moshirfar M, Shah TJ, et al. Eyelid cosmetic enhancements and their associated ocular adverse effects. Med Hypothesis Discov Innov Ophthalmol 2019;8:96–103.
De Cuyper C. Permanent makeup: indications and complications. Clin Dermatol 2008;26:30–34.
Wilson SE, Bannan RA, McDonald MB, et al. Corneal trauma and infection caused by manipulation of the eyelashes after application of mascara. Cornea 1990;9:181–182.
Verma RP, Matthews EJ. Estimation of the chemical-induced eye injury using a weight-of-evidence (WoE) battery of 21 artificial neural network (ANN) c-QSAR models (QSAR-21): part I: irritation potential. Regul Toxicol Pharmacol 2015;71:318–330.
Hirai Y, Hamada Y, Sasaki S, et al. Sarcoidosis and sarcoidal foreign body reaction after permanent eye makeup application: analysis by immunohistochemistry with commercially available antibodies specific to Cutibacterium acnes and Mycobacteria. J Cutan Pathol 2022;49:651–657.
Wang MT, Craig JP. Investigating the effect of eye cosmetics on the tear film: current insights. Clin Optom (Auckl) 2018;10:33–40.
Ercan ZE. Effect of eyeliner and mascara use on tear film and meibomian glands. Saudi J Ophthalmol 2022;36:113–116.
Murube J. Ocular cosmetics in modern times. Ocul Surf 2013;11:60–64.
Timbo BB, Chirtel SJ, Ihrie J, et al. Dietary supplement adverse event report data from the FDA Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS), 2004-2013. Ann Pharmacother 2018;52:431–438.
FDA. Using Adverse Event Reports to Monitor Cosmetic Safety. Available at: https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/how-report-cosmetic-related-complaint.
Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf 1999;20:109–117.
FDA. Cosmetic Products & Ingredients. Available at: https://www.fda.gov/cosmetics/cosmetic-products-ingredients.
FDA. What is a Serious Adverse Event? Available at: https://www.fda.gov/safety/reporting-serious-problems-fda/what-serious-adverse-event. Accessed January 21, 2024.
Raschi E, Girardi A, Poluzzi E, et al. Adverse events to food supplements containing red yeast rice: comparative analysis of FAERS and CAERS reporting systems. Drug Saf 2018;41:745–752.
Wallace RB, Gryzlak BM, Zimmerman MB, et al. Application of FDA adverse event report data to the surveillance of dietary botanical supplements. Ann Pharmacother 2008;42:653–660.
Jacob SL, Cornell E, Kwa M, et al. Cosmetics and cancer: adverse event reports submitted to the Food and Drug Administration. JNCI Cancer Spectr 2018;2:pky012.
Bakhati D, Agrawal S. COVID-19 pandemic lockdown-Is it affecting our skin hygiene and cosmetic practice? J Cosmet Dermatol 2022;21:1830–1836.
Gallardo MJ, Randleman JB, Price KM, et al. Ocular argyrosis after long-term self-application of eyelash tint. Am J Ophthalmol 2006;141:198–200.
Ansari ZA, Choi CJ, Rong AJ, et al. Ocular and cerebral infarction from periocular filler injection. Orbit 2019;38:322–324.
Fiume MZ, Yamarik TA. Final report on the safety assessment of 6-Amino-m-Cresol, 6-Amino-o-Cresol, 4-Amino-m-Cresol, 5-Amino-4-Chloro-o-Cresol, 5-Amino-6-Chloro-o-Cresol, and 4-Chloro-2-Aminophenol. Int J Toxicol 2004;23:1–22.
Becker LC; Cosmetic Ingredient Review Expert Panel. Final report on the safety assessment of 3-methylamino-4-nitrophenoxyethanol as used in hair dyes. Int J Toxicol 2008;27:41–51.
Rodrigues da Penha J, Garcia da Silva AC, de Ávila RI, et al. Development of a novel ex vivo model for chemical ocular toxicity assessment and its applicability for hair straightening products. Food Chem Toxicol 2022;170:113457.
Kamboj A, Spiller HA, Funk AR, et al. Cosmetics and personal care products-related ocular exposures reported to United States poison control centers. Ophthalmic Epidemiol 2022;29:573–581.
Venkatesh R, Pereira A, Reddy NG, et al. Retinal artery occlusion as a probable idiosyncratic reaction to topical minoxidil: a case report. J Med Case Rep 2021;15:493.
Borowska S, Brzóska MM. Metals in cosmetics: implications for human health. J Appl Toxicol 2015;35:551–572.
Wang J, Liu Y, Kam WR, et al. Toxicity of the cosmetic preservatives parabens, phenoxyethanol and chlorphenesin on human meibomian gland epithelial cells. Exp Eye Res 2020;196:108057.
Famele M, Lavalle R, Leoni C, et al. Quantification of preservatives in tattoo and permanent make-up inks in the frame of the new requirements under the REACH regulation. Contact Dermatitis 2022;87:233–240.
Kaluzhny Y, Kandárová H, Hayden P, et al. Development of the EpiOcular(TM) eye irritation test for hazard identification and labelling of eye irritating chemicals in response to the requirements of the EU cosmetics directive and REACH legislation. Altern Lab Anim 2011;39:339–364.
تواريخ الأحداث: Date Created: 20240813 Latest Revision: 20240813
رمز التحديث: 20240813
DOI: 10.1097/IOP.0000000000002718
PMID: 39136955
قاعدة البيانات: MEDLINE
الوصف
تدمد:1537-2677
DOI:10.1097/IOP.0000000000002718